EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma

Chun-Chi Chen iD, Pei-Yi Chu iD, Hung-Yu Lin iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24108807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chun-Chi Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Urology, Departments of Surgery, Changhua Christian Hospital, Changhua 500, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Counsil, Taiwan, Ministry of Science and Technology, National Health Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney renal clear cell carcinoma (KIRC) accounts for approximately 75% of all renal cancers. The prognosis for patients with metastatic KIRC is poor, with less than 10% surviving five years after diagnosis. Inner membrane mitochondrial protein (IMMT) plays a crucial role in shaping the inner mitochondrial membrane (IMM), regulation of metabolism and innate immunity. However, the clinical relevance of IMMT in KIRC is not yet fully understood, and its role in shaping the tumor immune microenvironment (TIME) remains unclear. This study aimed to investigate the clinical significance of IMMT in KIRC using a combination of supervised learning and multi-omics integration. The supervised learning principle was applied to analyze a TCGA dataset, which was downloaded and split into training and test datasets. The training dataset was used to train the prediction model, while the test and the entire TCGA dataset were used to evaluate its performance. Based on the risk score, the cutoff between the low and high IMMT group was set at median value. A Kaplan-Meier curve, receiver operating characteristic (ROC) curve, principal component analysis (PCA) and Spearman’s correlation were conducted to evaluate the prediction ability of the model. Gene Set Enrichment Analysis (GSEA) was used to investigate the critical biological pathways. Immunogenicity, immunological landscape and single-cell analysis were performed to examine the TIME. Databases including Gene Expression Omnibus (GEO), Human Protein Atlas (HPA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) were employed for inter-database verification. Pharmacogenetic prediction was analyzed via single-guide RNA (sgRNA)-based drug sensitivity screening using Q-omics v.1.30. Low expressions of IMMT in tumor predicted dismal prognosis in KIRC patients and correlated with KIRC progression. GSEA revealed that low expressions of IMMT were implicated in mitochondrial inhibition and angiogenetic activation. In addition, low IMMT expressions had associations with reduced immunogenicity and an immunosuppressive TIME. Inter-database verification corroborated the correlation between low IMMT expressions, KIRC tumors and the immunosuppressive TIME. Pharmacogenetic prediction identified lestaurtinib as a potent drug for KIRC in the context of low IMMT expressions. This study highlights the potential of IMMT as a novel biomarker, prognostic predictor and pharmacogenetic predictor to inform the development of more personalized and effective cancer treatments. Additionally, it provides important insights into the role of IMMT in the mechanism underlying mitochondrial activity and angiogenesis development in KIRC, which suggests IMMT as a promising target for the development of new therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansPrecision MedicinePrognosisClinical RelevanceMultiomicsProteomicsMitochondrial ProteinsSupervised Machine LearningKidneyTumor MicroenvironmentMuscle Proteins

Stichwörter der Autor:innen

biomarkerinner membrane mitochondrial proteinkidney renal clear cell carcinomaprecision medicineprognosissupervised learningtumor immune microenvironment

Substanzen

Mitochondrial ProteinsIMMT protein, humanMuscle Proteins

Autor:innen und Institutionen

  • Section of Urology, Departments of Surgery, Changhua Christian Hospital, Changhua 500, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung 402, Taiwan.
  • School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan.
  • Department of Pathology, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
  • National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan.
  • Research Assistant Center, Show Chwan Memorial Hospital, Changhua 500, Taiwan.

ORCID-Profile: Chun-Chi Chen, Pei-Yi Chu, Hung-Yu Lin

Förderung

  • National Science and Technology Counsil, Taiwan
  • Ministry of Science and Technology
  • National Health Research Institutes

Zitieren

APA

Chen, C. C., Chu, P. Y., & Lin, H. Y. (2023). Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108807

Vancouver

Chen CC, Chu PY, Lin HY. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108807

BibTeX
@article{Chen2023,
  author = {Chen, Chun-Chi and Chu, Pei-Yi and Lin, Hung-Yu},
  title = {Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24108807}
}
Kostenlos starten →